Skip to main content


Browse the latest news, expert commentary, and educational content on COVID-19.


08-03-2022 | COVID-19 | News

Temporary methotrexate withdrawal may improve COVID-19 vaccine immunogenicity

Findings from the CoronavRheum trial suggest that suspension of methotrexate for 2 weeks after each dose of the Sinovac inactivated SARS-CoV-2 vaccine may improve antibody response rates to vaccination among people with rheumatoid arthritis.

22-02-2022 | COVID-19 | News

Support for COVID-19 vaccination in adolescents with rheumatic diseases

Study findings suggest that mRNA vaccines against SARS-CoV-2 have good short-term safety and immunogenicity profiles in adolescents with juvenile-onset rheumatic diseases.

28-01-2022 | COVID-19 | Video | Article

Rituximab use in the COVID-19 era: Striking the right balance

With rituximab-treated patients having an elevated risk for severe COVID-19 and a reduced likelihood of responding to vaccines, Sebastian Sattui and David Jayne discuss how these challenges can be addressed and explore the future role of the drug for the treatment of rheumatic diseases.

Rituximab and rheumatology practice in the COVID-19 era

How can rheumatologists respond to the challenges associated with rituximab use during the pandemic?

COVID-19 in rheumatic disease patients

COVID-19 vaccination in patients with rheumatic diseases

Get answers to key questions with recommendations from professional organizations

Repurposing rheumatology drugs for COVID-19

Repurposing rheumatology drugs for COVID-19

Experts discuss the rationale, data on different agents, and the potential impact on rheumatology practice.

COVID-19 guidance for rheumatologists

Telemedicine in rheumatology

Experts discuss the increasing use of telemedicine in rheumatology during the COVID-19 pandemic.

Keep up with podcasts on this topic, available on

Stay informed with Medicine Matters

Get the latest developments in rheumatology delivered straight to your inbox